Figure 3From: Levels of HOXB7 and miR-337 in pancreatic ductal adenocarcinoma patientsKaplan-Meier curves of the clinical outcome in PDAC patients. A) Survival curves of different tumor size in patients with PDAC (P=0.021). B) Survival curves of differentiations in patients with PDAC (P=0.016). C) Survival curves of different TNM stages in patients with PDAC (P=0.003). D) Survival curves of lymph node metastatic group and non-metastatic group in patients with PDAC (P=0.000). E) Survival curves of different HOXB7 protein level groups in patients with PDAC (P=0.012). F) Survival curves of different miR-337 level groups in patients with PDAC (P=0.002).Back to article page